Development of Glioblastoma Multiforme in Patients With Human Papillomavirus‐Positive Oropharyngeal Squamous Cell Carcinoma: A Case Series
Cancer Reports · 2026-03 · 9 (3)
DOI: 10.1002/cnr2.70521 ↗Kurz gefasst
Fallbericht in der Zeitschrift Cancer Reports, online erschienen am 20.03.2026. Verfasst von Jessica T Lovett und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, NYU Grossman School of Medicine, New York, New York, USA. Hauptthemen laut MEDLINE: Glioblastoma, Oropharyngeal Neoplasms, Papillomavirus Infections, Neoplasms, Second Primary. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Icahn School of Medicine at Mount Sinai, Icahn School of Medicine at Mount Sinai.
Abstract (Originalsprache)
Background
Human papillomavirus‐positive oropharyngeal squamous cell carcinoma (HPV+ OPC) patients typically exhibit reduced rates of second primary malignancies (SPMs) compared to HPV‐negative head and neck cancer patients. While HPV+ OPC patients may be predisposed to SPMs in HPV‐associated anatomical sites, the metachronous presentation of an HPV+ OPC and subsequent glioblastoma multiforme (GBM) has not been previously documented. Cases We present two cases of HPV+ OPC patients who developed GBMs within a short period after definitive therapy.
Methods
Comprehensive whole exome sequencing (WES) was performed on paired GBM, oropharyngeal, and matched normal tissues from two HPV+ OPC patients who developed GBMs within a short period after definitive therapy, with the goal of identifying shared somatic and germline variants. Bioinformatic analyses included variant calling, annotation, and pathway enrichment.
Results
WES revealed a shared CEP104 missense mutation among both oropharyngeal tumors as well as a potential KIR2DL4 germline variant in the second patient, suggesting a possible role for disrupted NK cell immunity in driving these cancers.
Conclusion
Although these cases were likely random events, they illustrate the diagnostic and therapeutic challenges of GBM following HPV+ OPC and underscore the importance of personalized genomic assessment in HPV+ OPC survivors, who may develop non‐head and neck SPMs unrelated to field cancerization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Internal Medicine, NYU Grossman School of Medicine, New York, New York, USA.
- Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
- Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Department of Anatomic Pathology, Moffitt Cancer Center, Tampa, Florida, USA.
- Tampa General Hospital Cancer Institute/Cancer Center of South Florida, Tampa, Florida, USA.
ORCID-Profile: Jessica T Lovett, Michael Wotman, Ryan Denu, Aishwarya Mandava, Hardik Shah, Robert Sebra, William Westra, Marshall Posner
Förderung
- the Icahn School of Medicine at Mount Sinai
- Icahn School of Medicine at Mount Sinai
Zitieren
APA
Lovett, J. T., Wotman, M., Denu, R., Mandava, A., Shah, H., Sebra, R., Westra, W., & Posner, M. (2026). Development of Glioblastoma Multiforme in Patients With Human Papillomavirus‐Positive Oropharyngeal Squamous Cell Carcinoma: A Case Series. Cancer Reports, 9(3). https://doi.org/10.1002/cnr2.70521
Vancouver
Lovett JT, Wotman M, Denu R, Mandava A, Shah H, Sebra R, et al. Development of Glioblastoma Multiforme in Patients With Human Papillomavirus‐Positive Oropharyngeal Squamous Cell Carcinoma: A Case Series. Cancer Reports. 2026;9(3). doi:10.1002/cnr2.70521
BibTeX
@article{Lovett2026,
author = {Lovett, Jessica T and Wotman, Michael and Denu, Ryan and Mandava, Aishwarya and Shah, Hardik and Sebra, Robert and Westra, William and Posner, Marshall},
title = {Development of Glioblastoma Multiforme in Patients With Human Papillomavirus‐Positive Oropharyngeal Squamous Cell Carcinoma: A Case Series},
journal = {Cancer Reports},
year = {2026},
volume = {9},
number = {3},
doi = {10.1002/cnr2.70521}
}
EUVIMED